Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Sullivan

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
Endothelin and erectile dysfunction: a target for pharmacological intervention?M A Khan, C S Thompson, M E Sullivan, et al.
BJU International|July 25, 2000
Endothelins in the urinary tractM E Sullivan, F H Mumtaz, M A Khan, et al.
Current Drug Targets|July 24, 2001
Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonistsM A Khan, R C Calvert, M E Sullivan, et al.
Endothelium : Journal of Endothelial Cell Research|December 22, 1999
Potential role of endothelin and nitric oxide in physiology and pathophysiology of the lower urinary tractF H Mumtaz, M A Khan, M E Sullivan, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1997
The paracrine endothelin system: pathophysiology and implications in clinical medicineM R Dashwood, F H Mumtaz, M E Sullivan, et al.
European Urology|January 1, 1996
Autoradiographic localization of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosumM E Sullivan, C R Bell, M R Dashwood, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1980
Percutaneous transluminal angioplasty in the management of occlusive disease involving the coronary arteries and saphenous vein bypass grafts: preliminary resultsW B Ford, M H Wholey, E A Zikria, et al.
Urological Research|September 30, 2000
Inhibition of diabetic bladder smooth muscle cell proliferation by endothelin receptor antagonistsF H Mumtaz, N Shukla, M E Sullivan, et al.
Journal of Medicinal Chemistry|March 2, 1992
Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agentsG B Phillips, T K Morgan, W C Lumma, et al.
Journal of Medicinal Chemistry|February 1, 1990
Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agentsG B Phillips, T K Morgan, K Nickisch, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|July 5, 2005
Endothelin and erectile dysfunction: a target for pharmacological intervention?M A Khan, C S Thompson, M E Sullivan, et al.
BJU International|July 25, 2000
Endothelins in the urinary tractM E Sullivan, F H Mumtaz, M A Khan, et al.
Current Drug Targets|July 24, 2001
Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonistsM A Khan, R C Calvert, M E Sullivan, et al.
Endothelium : Journal of Endothelial Cell Research|December 22, 1999
Potential role of endothelin and nitric oxide in physiology and pathophysiology of the lower urinary tractF H Mumtaz, M A Khan, M E Sullivan, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1997
The paracrine endothelin system: pathophysiology and implications in clinical medicineM R Dashwood, F H Mumtaz, M E Sullivan, et al.
European Urology|January 1, 1996
Autoradiographic localization of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosumM E Sullivan, C R Bell, M R Dashwood, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1980
Percutaneous transluminal angioplasty in the management of occlusive disease involving the coronary arteries and saphenous vein bypass grafts: preliminary resultsW B Ford, M H Wholey, E A Zikria, et al.
Urological Research|September 30, 2000
Inhibition of diabetic bladder smooth muscle cell proliferation by endothelin receptor antagonistsF H Mumtaz, N Shukla, M E Sullivan, et al.
Journal of Medicinal Chemistry|March 2, 1992
Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agentsG B Phillips, T K Morgan, W C Lumma, et al.
Journal of Medicinal Chemistry|February 1, 1990
Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agentsG B Phillips, T K Morgan, K Nickisch, et al.
Pageof 8